266 related articles for article (PubMed ID: 21527366)
21. Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study.
Nounou MI; Adkins CE; Rubinchik E; Terrell-Hall TB; Afroz M; Vitalis T; Gabathuler R; Tian MM; Lockman PR
Pharm Res; 2016 Dec; 33(12):2930-2942. PubMed ID: 27528392
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic disruption of the blood brain barrier in metastasis.
Jandial R; Neman J; Chen MY
Neurosurgery; 2014 Apr; 74(4):N11-2. PubMed ID: 24642987
[No Abstract] [Full Text] [Related]
23. Factors influencing survival in patients with breast cancer and single or solitary brain metastasis.
Niwińska A; Pogoda K; Murawska M; Niwiński P
Eur J Surg Oncol; 2011 Jul; 37(7):635-42. PubMed ID: 21664097
[TBL] [Abstract][Full Text] [Related]
24. Distribution analysis of epertinib in brain metastasis of HER2-positive breast cancer by imaging mass spectrometry and prospect for antitumor activity.
Tanaka Y; Hirata M; Shinonome S; Torii M; Nezasa KI; Tanaka H
Sci Rep; 2018 Jan; 8(1):343. PubMed ID: 29321587
[TBL] [Abstract][Full Text] [Related]
25. Adaptation of energy metabolism in breast cancer brain metastases.
Chen EI; Hewel J; Krueger JS; Tiraby C; Weber MR; Kralli A; Becker K; Yates JR; Felding-Habermann B
Cancer Res; 2007 Feb; 67(4):1472-86. PubMed ID: 17308085
[TBL] [Abstract][Full Text] [Related]
26. HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients.
Wolstenholme V; Hawkins M; Ashley S; Tait D; Ross G
Breast; 2008 Dec; 17(6):661-5. PubMed ID: 18571923
[TBL] [Abstract][Full Text] [Related]
27. Biological therapy of breast cancer: recent clinical applications.
Baar J
Curr Opin Investig Drugs; 2007 Dec; 8(12):987-95. PubMed ID: 18058569
[TBL] [Abstract][Full Text] [Related]
28. HER2 status in patients with breast carcinoma is not modified selectively by preoperative chemotherapy and is stable during the metastatic process.
Vincent-Salomon A; Jouve M; Genin P; Fréneaux P; Sigal-Zafrani B; Caly M; Beuzeboc P; Pouillart P; Sastre-Garau X
Cancer; 2002 Apr; 94(8):2169-73. PubMed ID: 12001113
[TBL] [Abstract][Full Text] [Related]
29. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
[TBL] [Abstract][Full Text] [Related]
30. Survival in patients with brain metastases from breast cancer: the importance of HER-2 status.
Eichler AF; Kuter I; Ryan P; Schapira L; Younger J; Henson JW
Cancer; 2008 Jun; 112(11):2359-67. PubMed ID: 18361426
[TBL] [Abstract][Full Text] [Related]
31. Current therapeutic options for breast cancer central nervous system metastases.
Hemphill MB; Lawrence JA
Curr Treat Options Oncol; 2008 Feb; 9(1):41-50. PubMed ID: 18392684
[TBL] [Abstract][Full Text] [Related]
32. The impact of receptor conversion on treatment efficacy and survival in breast cancer patients with brain metastases: Still debatable issue?
Abduyev Z; Altundag K
J BUON; 2019; 24(4):1738. PubMed ID: 31646839
[No Abstract] [Full Text] [Related]
33. The Biology of Brain Metastasis: Challenges for Therapy.
Fidler IJ
Cancer J; 2015; 21(4):284-93. PubMed ID: 26222080
[TBL] [Abstract][Full Text] [Related]
34. Molecular and cellular mechanisms underlying brain metastasis of breast cancer.
Hosonaga M; Saya H; Arima Y
Cancer Metastasis Rev; 2020 Sep; 39(3):711-720. PubMed ID: 32399646
[TBL] [Abstract][Full Text] [Related]
35. Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer.
Adkins CE; Mohammad AS; Terrell-Hall TB; Dolan EL; Shah N; Sechrest E; Griffith J; Lockman PR
Clin Exp Metastasis; 2016 Apr; 33(4):373-83. PubMed ID: 26944053
[TBL] [Abstract][Full Text] [Related]
36. Current challenges in the management of breast cancer brain metastases.
O'Sullivan CC; Davarpanah NN; Abraham J; Bates SE
Semin Oncol; 2017 Apr; 44(2):85-100. PubMed ID: 28923217
[TBL] [Abstract][Full Text] [Related]
37. Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?
Kabraji S; Ni J; Lin NU; Xie S; Winer EP; Zhao JJ
Clin Cancer Res; 2018 Apr; 24(8):1795-1804. PubMed ID: 29437794
[TBL] [Abstract][Full Text] [Related]
38. [Trastuzumab and blood-brain barrier].
Platini C
Bull Cancer; 2007 Oct; 94(10):857-9. PubMed ID: 17964978
[TBL] [Abstract][Full Text] [Related]
39. Brain metastases of breast cancer.
Palmieri D; Smith QR; Lockman PR; Bronder J; Gril B; Chambers AF; Weil RJ; Steeg PS
Breast Dis; 2006-2007; 26():139-47. PubMed ID: 17473372
[TBL] [Abstract][Full Text] [Related]
40. Brain metastases in breast cancer.
Sim HW; Morris PG; Patil S; Khasraw M
Expert Rev Anticancer Ther; 2014 Feb; 14(2):173-83. PubMed ID: 24308683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
